2m 2m 2m 2m 2m 2m 2m
ARCUS BIOSCIENS (RCUS)
NYSE
$24.41-$0.18 (-0.75%)
Price as of Sep 11, 2026 8:00 PM EDT- $3.1BMarket Cap
- 113.45%1-Year Change
- BiotechnologyIndustry
ARCUS BIOSCIENS (RCUS)
$24.41-$0.18 (-0.75%)
RCUS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $24.59 | ||
Change | -$1.56 (-5.97%) | ||
Open | $26.50 | ||
High | $26.58 | ||
Low | $24.32 | ||
Previous Close | $26.15 | ||
Volume | 4,277,165 | ||
30-Day Average Volume | 1,374,766 | ||
1-Week Change | -17.09% | ||
1-Month Change | -14.44% | ||
1-Year Change | 113.45% | ||
3-Year Change | 18.28% | ||
5-Year Change | -24.08% | ||
Fundamentals | |||
Shares Outstanding | 127.3M | ||
Total Assets | $924.0M | ||
Market Cap | $3.1B | ||
Enterprise Value | $3.1B | ||
Period: QTR TTM FY | |||
Revenue | $8.0M | ||
Net Income | -$91.0M | ||
Free Cash Flow | -$119.0M | ||
EBIT | -$88.0M | ||
EBITDA | -$85.0M | ||
Net Working Capital | $558.0M | ||
EPS | -$0.72 | ||
Enterprise Value/EBITDA | -36 | ||
Enterprise Value/Revenue | 385 | ||
P/B | 7 | ||
P/E | -34 | ||
PEG | -1 | ||
Price/Free Cash Flow | -26 | ||
Price/Operating Cash Flow | -26 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue